LENZ

$4.72-3.87%

LENZ Therapeutics, Inc.

Market Cap

$154M

Sector

Materials

Industry

Pharmaceuticals

Beta

0.72

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

13 analysts

Velocity Score

25.65x

Current Rate (90d)

457.57/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

3

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-03-27	2026-03-30	George Jeffrey P.	Director	Purchase	5,592	$8.92	$50K	5,592	View
2026-03-27	2026-03-30	Schimmelpennink Evert B.	Director & President, CEO and Secretary	Purchase	28.1K	$8.95	$251K	77.3K	View
2026-03-27	2026-03-30	Chevallard Daniel R.	Chief Financial Officer	Purchase	7,500	$8.57	$64K	12.9K	View

Recent News

LENZ Therapeutics: Still Speculative But Priced For Disasters

SeekingAlpha · 2026-09-04

LENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript

Yahoo Finance · 2026-08-19

LENZ Therapeutics (LENZ) Stock Sees Fair Value Moves Lower After Analyst Target Cuts

Yahoo · 2026-08-15

Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $7

Benzinga · 2026-08-12

Informational purposes only, not investment advice.